• Explore /
  • Poster
  • / Safety and efficacy of trifluridine/tipiracil (FTD/TPI) plus bevacizumab in clinical practice for patients with chemorefractory metastatic colorectal cancer: A retrospective comparative study.

Safety and efficacy of trifluridine/tipiracil (FTD/TPI) plus bevacizumab in clinical practice for patients with chemorefractory metastatic colorectal cancer: A retrospective comparative study.

Abstract Poster

Authors

null

Yoshinori Kagawa

Department of Surgery, Kansai Rosai Hospital, Amagasaki, Japan

Yoshinori Kagawa , Yohei Nose , Taishi Hata , Kenji Kawai , Takuya Sakamoto , Kohei Murakami , Yoshiteru Katsura , Yoshiaki Ohmura , Toru Masuzawa , Atsushi Takeno , Yutaka Takeda , Kohei Murata

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Anal and Colorectal Cancer

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 112)

Abstract #

112

Poster Bd #

E20

Abstract Disclosures

Similar Posters

First Author: Julien Taieb

First Author: Eiji Shinozaki

First Author: Lorenzo Antonuzzo

First Author: Nieves Martinez Lago